| dc.creator |
Tola, Esra Nur |
|
| dc.creator |
DUGAN, Nadiye |
|
| dc.creator |
Yalcin, Serenat |
|
| dc.date |
2017-06-30T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T10:31:58Z |
|
| dc.date.available |
2020-10-06T10:31:58Z |
|
| dc.identifier |
711c5e98-06af-42ef-8f8d-79deff16807b |
|
| dc.identifier |
10.1016/j.ejogrb.2017.05.014 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/711c5e98-06af-42ef-8f8d-79deff16807b/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/63203 |
|
| dc.description |
Objective(s): The aim of our study is to analyse the inflammatory markers and lipid accumulation product (LAP) index in nonobese adolescents and younger aged women with polycystic ovary syndrome (PCOS) compared with age and body mass index (BMI)-matched healthy controls and to determine whether the investigated parameters are potential markers for the etiopathogenesis of PCOS. We also aim to determine whether these inflammatory markers are predictive for developing some clinical implications, such as cardiovascular disease (CVD) and insulin resistance (IR), associated with PCOS. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women |
|
| dc.type |
info:eu-repo/semantics/article |
|